ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
NexGel Inc

NexGel Inc (NXGL)

3.04
-0.10
( -3.18% )
Updated: 13:19:11

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
3.04
Bid
2.91
Ask
3.05
Volume
43,973
2.80 Day's Range 3.15
1.46 52 Week Range 3.24
Market Cap
Previous Close
3.14
Open
3.14
Last Trade
4
@
2.975
Last Trade Time
13:17:44
Financial Volume
$ 130,746
VWAP
2.9733
Average Volume (3m)
37,736
Shares Outstanding
6,227,624
Dividend Yield
-
PE Ratio
-5.52
Earnings Per Share (EPS)
-0.51
Revenue
4.09M
Net Profit
-3.16M

About NexGel Inc

NexGel Inc manufactures high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company specializes in custom gels by capitalizing on proprietary manufacturing technologies. The gels a... NexGel Inc manufactures high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company specializes in custom gels by capitalizing on proprietary manufacturing technologies. The gels and consumer products are manufactured using proprietary and non-proprietary mixing, coating, and cross-linking technologies. The company recognizes revenue from contract manufacturing. Show more

Sector
Surgical,med Instr,apparatus
Industry
Surgical,med Instr,apparatus
Website
Headquarters
Wilmington, Delaware, USA
Founded
1970
NexGel Inc is listed in the Surgical,med Instr,apparatus sector of the NASDAQ with ticker NXGL. The last closing price for NexGel was $3.14. Over the last year, NexGel shares have traded in a share price range of $ 1.46 to $ 3.24.

NexGel currently has 6,227,624 shares outstanding. The market capitalization of NexGel is $19.55 million. NexGel has a price to earnings ratio (PE ratio) of -5.52.

NXGL Latest News

NEXGEL and Innovative Optics US Initiate Institutional Review Board (IRB) Study in Accordance with FDA of Hydrogel Application During Laser Hair Removal

The 30-patient study is designed to measure the efficacy of applying NEXGEL’s hydrogel during laser hair removal in eliminating harmful particles or plume during treatments Several states have...

NEXGEL Announces Preliminary Record Second Quarter 2024 Revenue of $1.4 Million and Issues Revenue Guidance for Third and Fourth Quarter of 2024 of $2.2 Million and $2.6 Million, Respectively

LANGHORNE, Pa., July 08, 2024 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: NXGL), a leading provider of medical and over-the-counter (OTC) products including...

NEXGEL Subsidiary, CG Converting and Packaging, Announces it will Supply SilverSeal to Cintas Corporation

LANGHORNE, Pa., June 27, 2024 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: NXGL), a leading provider of medical and over-the-counter (OTC) products including...

NEXGEL and STADA Partner to Launch Leading European DAO Enzyme Supplement, Histasolv, in North America

LANGHORNE, Pa., June 11, 2024 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: NXGL), a leading provider of medical and over-the-counter (OTC) products including...

NEXGEL Acquires International Beauty Brand, Silly George

Acquisition further expands NEXGEL Health, Wellness, and Beauty consumer product portfolio Silly George is on a revenue run rate of approximately $2 million LANGHORNE, Pa., May 16, 2024 (GLOBE...

NEXGEL Reports First Quarter 2024 Revenue of $1.27 Million, an Increase of 104% Year-Over-Year

LANGHORNE, Pa., May 13, 2024 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of ultra-gentle, high-water-content hydrogel products for...

NEXGEL to Report First Quarter 2024 Financial Results on May 13th

Management will host a conference call at 4:30 P.M. ET on the same day LANGHORNE, Pa., May 09, 2024 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading...

NEXGEL to Present at the Aegis Capital Virtual Conference on May 9, 2024

LANGHORNE, Pa., May 06, 2024 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of medical and over-the-counter (OTC) products including...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.3211.76470588242.723.242.551501553.00995188CS
40.8740.09216589862.173.241.95852982.72933884CS
120.8438.18181818182.23.241.84377362.59887354CS
260.8236.93693693692.223.241.84286222.56604945CS
520.7331.60173160172.313.241.46257382.33149434CS
156-1.36-30.90909090914.44.661.09732852.54388267CS
260-1.36-30.90909090914.44.661.09732852.54388267CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
RDHLRedhill Biopharma Ltd
$ 0.652
(69.75%)
275.65M
DRMADermata Therapeutics Inc
$ 2.4957
(45.10%)
17.36M
BBLGBone Biologics Corporation
$ 2.94
(36.11%)
64.57M
ATPCAgape ATP Corporation
$ 0.157
(35.70%)
125.09M
SPGCSacks Parente Golf Inc
$ 5.50
(30.33%)
654.4k
VWEVintage Wine Estates Inc
$ 0.029
(-44.12%)
34.15M
LABStandard BioTools Inc
$ 1.315
(-41.29%)
7.73M
ALXOALX Oncology Holdings Inc
$ 2.965
(-38.23%)
6.63M
RENBRenovaro Inc
$ 0.52425
(-28.18%)
1.28M
ATECAlphatec Holdings Inc
$ 7.405
(-26.68%)
9.97M
NVDANVIDIA Corporation
$ 108.825
(-7.00%)
292.73M
RDHLRedhill Biopharma Ltd
$ 0.652
(69.75%)
275.65M
SQQQProShares UltraPro Short QQQ
$ 9.258
(7.78%)
193.38M
ATPCAgape ATP Corporation
$ 0.157
(35.70%)
125.09M
HUGEFSD Pharma Inc
$ 0.1081
(7.03%)
78.44M

NXGL Discussion

View Posts
Monksdream Monksdream 2 months ago
NXGL under $3
👍️0
tdag910 tdag910 5 months ago
Winner winner chicken dinner!!
👍️0
Pinksatthehotel Pinksatthehotel 5 months ago
Looking good!
👍️0
tdag910 tdag910 9 months ago
Anybody home?
👍️0
alyck alyck 1 year ago
NXGL looking great! Solidly over $2 and volume increasing. Keep it going
👍️0
81vette 81vette 1 year ago
Ended @New 52 week high,blue sky babe!! Enjoy the weekend everyone!!
👍️0
81vette 81vette 1 year ago
contracts with pro sports teams will make brand huge,building a great company,investment in packaging plant was wise
👍️0
81vette 81vette 1 year ago
For the first quarter of 2023, revenue totaled $620 thousand and increased by $224 thousand, or 56.6%, compared to $396 thousand for the same period the year prior. The increase in overall revenues was primarily due to sales growth in both contract manufacturing and branded products. Revenue during the first quarter of 2023 includes one full month of revenue contribution from the Company’s newly formed joint venture with C.G. Laboratories.first quarter we delivered 56.6% revenue growth year-over-year, driven by increased sales in contract manufacturing and branded consumer products. We also started to see contribution in March from our new joint venture with CG Labs. During the quarter, we launched several new products and invested strategically in sales and marketing to support those launches. We are already starting to see the financial returns from these investments in the second quarter, as well as from our new JV.” “Based on the dynamic changes to our business, which include the March 1 joint venture, I feel it’s important to provide a one-time exception to our policy of not providing guidance. Based on these developments and our progress to date, we are projecting $1.0 million in revenue for the second quarter of 2023, an increase of 78.2% year-over-year. Complementing this, we had approximately $5.8 million in cash and cash equivalents at quarter-end, which gives us sufficient runway to operate and the ability to be opportunistic about further potential investments to accelerate our growth.”Acquired a 50% interest in a newly formed joint venture (“JV”), CG Converting and Packaging, LLC, with C.G. Laboratories Inc. (“CG Labs”) for its converting and packaging business.
Executed a supply agreement with a large new customer relating to a new consumer product.Launched advertising and marketing initiative, which has increased branded product sales.
👍️ 1
81vette 81vette 1 year ago
watch demand,next move up thru 52 week high,very low supply atm
👍️0
81vette 81vette 1 year ago
GOLDEN CROSS is best indicator of long bulls,follow the money is the saying
👍️0
81vette 81vette 1 year ago
eps q/q up 60%,is why moving up,big profit coming,great future $ deals,expect institutions loading long,way undervalued@ 10M mkt cap
👍️0
81vette 81vette 1 year ago
GOLDEN CROSS now,thru triple top res.,52week high>$2.00,then blue sky
👍️0
81vette 81vette 1 year ago
4M float,5M o/s,.52%short,buy vol 15X ave,not optionable,shares borrow ava. dropped 400% with pre-mkt volume,easily could go ZERO BORROW with this low float/os
👍️0

Your Recent History

Delayed Upgrade Clock